NASDAQ · ALOY

REalloys Inc.

$7.03 -$0.44 (-5.96%) 1D After hours

Key Metrics

$509.69M
Market cap
P/E · TTM
$706.00K
Revenue · TTM
−$110.31M
Net income
EPS · TTM $-3.38
Dividend yield
Free cash flow
Beta · 1Y
EBITDA · TTM −$91.16M
Gross margin 130.6%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 24
    From its Mar 4 high, the share price fell 73%.

    Peak close $25.88 on Mar 4; trough close $7.03 on Jul 24. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -73%
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Apr 9
    The stock moved +23.7% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Apr 9
  • Feb 27
    The stock moved +32.1% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 27

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$509.69M
Enterprise value$507.84M
Shares outstanding68.2M
52-wk range$6.83 – $26.90
Avg volume · 20D2.2M
Net cash $1.85M
Book value / share$3.12
IndustryMetal Mining
ExchangeNASDAQ
About REalloys Inc.
IPO dateFeb 25, 2026
Employees

REalloys Inc is an integrated company focused on the development and production of rare earth elements, with a primary assets.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S721.93
P/FCF
EV/EBITDA
EV/Sales719.32
Graham №

Profitability

Gross 130.6%
Operating -12,925.5%
Net -15,625.4%
FCF
ROE / ROIC -206.3% · —

Financial Health

Current ratio5.04
Quick ratio5.04
Debt / equity0.00
Debt / EBITDA 0.00
Net cash $1.85M
Working capital$58.93M

Cash Flow · TTM

Operating CF −$13.07M
Capex
Free cash flow
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

1 / 9
Weak fundamentals · 1 of 9 signals passing

Altman Z-Score

6.8
Safe zone (> 2.99) · bankruptcy risk negligible

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings